Provided by Tiger Trade Technology Pte. Ltd.

ACRES Commercial Realty Corp.

14.28
+0.14000.99%
Post-market: 14.280.00000.00%16:10 EDT
Volume:44.16K
Turnover:627.31K
Market Cap:101.83M
PE:-12.86
High:14.50
Open:14.03
Low:14.00
Close:14.14
52wk High:24.61
52wk Low:13.68
Shares:7.13M
Float Shares:7.13M
Volume Ratio:1.52
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1100
EPS(LYR):0.0300
ROE:5.46%
ROA:1.27%
PB:0.25
PE(LYR):476.02

Loading ...

Press Release: ACRES COMMERCIAL REALTY CORP. REPORTS RESULTS FOR FIRST QUARTER 2026

Dow Jones
·
Apr 30

Acres Commercial Realty Corp. Announces Agreement to Internalize Management and Acquire Acres Capital Corp.

THOMSON REUTERS
·
Apr 30

Acres Commercial Realty Corp - to Issue 7.5 Mln Shares to Acc Stockholders at Fully Diluted Book Value as of Dec 31, 2025

THOMSON REUTERS
·
Apr 30

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 29

Acres Commercial Realty Corp expected to post earnings of 17 cents a share - Earnings Preview

Reuters
·
Apr 28

Palmer Luckey Says Smart TVs Pose 'Massive And Growing' Problem For American National Security: 'Users Have No Idea'

Benzinga
·
Apr 20

Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Development Opportunities

GlobeNewswire
·
Apr 18

Acres Commercial Realty sets first-quarter earnings release, schedules investor conference call

Reuters
·
Apr 16

Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

GlobeNewswire
·
Mar 27

Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire
·
Mar 27

ACRES Commercial Realty declares USD 0.6 Series C preferred dividend

Reuters
·
Mar 20

Acrivon plans to initiate fourth cohort in ACR-368 Phase 2b study

TIPRANKS
·
Mar 19

Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immune Checkpoint Inhibitors

GlobeNewswire
·
Mar 18

Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting

GlobeNewswire
·
Mar 10